Abstract
A critical appraisal and clinical application of Devinsky O, Cross H, Laux L, et al. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017;376(21):2011-2020. doi: 10.1056/NEJMoa1611618.
DOI
10.22237/crp/1567555380
Recommended Citation
DESAI N. Cannabidiol is beneficial in management of drug-resistant Dravet syndrome. Clin. Res. Prac. 2019 Sep 5;5(2):eP1844. doi: 10.22237/crp/1567555380
Included in
Chemicals and Drugs Commons, Medical Education Commons, Medical Neurobiology Commons, Medical Pharmacology Commons, Other Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons, Therapeutics Commons, Translational Medical Research Commons
